Lv2
196 积分 2024-07-30 加入
Risk Evaluation of N-Nitrosamines in Drug-Linker Intermediates Used To Generate Antibody–Drug Conjugates
16天前
已完结
Determination of the experimental extinction coefficient of therapeutic proteins using the Edelhoch method
3个月前
已完结
A multifaceted approach to understanding protein-buffer interactions in biopharmaceuticals
3个月前
已完结
Antibody disulfide bond reduction and recovery during biopharmaceutical process development—A review
3个月前
已完结
Innovative antibody therapeutic development in China compared with the USA and Europe
4个月前
已完结
Unique Impacts of Methionine Oxidation, Tryptophan Oxidation, and Asparagine Deamidation on Antibody Stability and Aggregation
4个月前
已完结
Über den jetzigen Stand der Chemotherapie
5个月前
已完结
Control of Regulatory T Cell Development by the Transcription Factor Foxp3
5个月前
已完结
Tolerability of hypertonic injectables
6个月前
已完结
Predicting the Long-Term Stability of Biologics with Short-Term Data
6个月前
已完结
皖公网安备34019202002308
